Viewing nowCombinationTri-1 Tablet 40/5/5mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.

MFDS item code 201802226 · Approved 2018.05.30 · Insurance code 671806590
Treatment of hypertension, improvement of dyslipidemia, and inhibition of the progression of atherosclerosis and cardiovascular disease risk
This drug is administered to patients with essential hypertension whose blood pressure is not adequately controlled even with the combination of telmisartan and amlodipine, and in cases where rosuvastatin is needed to be taken simultaneously. Rosuvastatin is used as an adjunct therapy when dietary and exercise interventions are insufficient for managing hypercholesterolemia and mixed dyslipidemia. Additionally, it helps in the treatment of familial hypercholesterolemia or dysbetalipoproteinemia, reducing total cholesterol and LDL-cholesterol, thus delaying the progression of atherosclerosis. This drug is also used to reduce the risk of stroke, myocardial infarction, and the need for arterial revascularization to lower the risk of cardiovascular disease. Therefore, this medication is effective in treating patients with hypertension, hyperlipidemia, and cardiovascular risk.
Take 1 tablet once daily with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking a telmisartan/amlodipine combination and rosuvastatin as separate medicines, this medicine (a combination product containing the same amounts of each active ingredient) may be substituted for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, a direct switch to the telmisartan/amlodipine combination may be considered as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. - 80/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or this medicine 40/10 milligrams. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: In patients 75 years of age or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Since systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of rosuvastatin 40 milligrams is contraindicated in some of these patients.
This drug may cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to any component of this drug or similar medications, or those with specific diseases, should not take this medication. It must be used cautiously in patients with severely impaired liver or kidney function, certain heart conditions, and muscle disorders. Elderly patients, individuals with excessively low blood pressure, or those with hyperkalemia must also take this drug with caution and should undergo regular liver function and muscle-related tests. This drug may cause symptoms such as muscle pain or weakness; if such symptoms occur, immediate consultation with a doctor is required. There may be interactions with other medications, so inform your doctor or pharmacist if you are taking any other drugs. Women of childbearing age should use appropriate contraception; for nursing mothers, it is advisable to either avoid taking this medication or stop breastfeeding. Not recommended for children under 18, as safety has not been established. In case of overdose, symptoms such as hypotension, dizziness, and in severe cases, kidney dysfunction may occur, so it is necessary to seek immediate medical attention. This medication should be stored out of reach of children and should not be transferred to other containers.
Viral upper respiratory tract infection, dyspnea, rectal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, hiatal hernia, dysuria, rhinitis, oropharyngeal discomfort, pulmonary disease, unspecified gastrointestinal disorders, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, headache, dizziness, orthostatic hypotension, low back pain, edema, flushing, palpitations, fatigue, nausea, abdominal pain, drowsiness, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, vasculitis, peripheral neuropathy, sensory disturbance, tremor, vertigo, loss of appetite, constipation, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia, allergic reaction, burning sensation, malaise, pain, stiffness, weight gain, weight loss, arthralgia, osteoarthritis, muscle cramps, myalgia, erectile dysfunction, insomnia, nervousness, depression, abnormal dreams, anxiety, depersonalization, angioedema, erythema multiforme, pruritus, rash, erythematous rash, papular rash, visual disturbances, conjunctivitis, diplopia, ocular pain, ear pain, frequent urination, urinary dysfunction, nocturia, dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, angioedema, headache, asthenia, cough, weakness, facial edema, lower extremity edema, pruritus, hypersensitivity reaction, increased perspiration, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, elevated blood pressure, worsening hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, urinary tract infection, erectile dysfunction, muscle cramps, bradycardia, eosinophilia, thrombocytopenia, elevated uric acid, liver dysfunction, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, rhabdomyolysis, angioedema, erectile dysfunction, headache, dizziness, constipation, nausea, abdominal pain, pruritus, myalgia, myopathy, rhabdomyolysis, asthenia, hematuria, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, amnesia, peripheral neuropathy, cough, diarrhea, jaundice, hepatitis, abnormal liver function tests, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light; therefore, it should be stored in a container that prevents light exposure. Additionally, it should be kept at room temperature between 1°C to 30°C. This will help maintain the drug's efficacy and safety.
Pink oval film-coated tablets
30 tablets (10 tablets x 3)/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
DaeWon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.